Cervical Intraepithelial Neoplasia Grade 2/3
Information
- Disease name
- Cervical Intraepithelial Neoplasia Grade 2/3
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03064087 | Active, not recruiting | Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples | December 29, 2017 | November 17, 2027 | |
NCT03196180 | Active, not recruiting | Early Phase 1 | Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia | September 30, 2019 | November 4, 2024 |
NCT04484415 | Active, not recruiting | Phase 3 | Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) | November 10, 2020 | December 2023 |
NCT00081263 | Completed | Phase 2 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | June 2005 | |
NCT02354534 | Completed | Phase 1 | Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) | February 2015 | November 6, 2018 |
NCT04312737 | Completed | Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus | July 16, 2020 | March 15, 2022 | |
NCT02811367 | Completed | N/A | The HPV Self-test as a Test of Cure in Madagascar | June 2016 | September 2016 |
NCT01550783 | Completed | N/A | Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening | March 2012 | November 16, 2017 |
NCT02067468 | Completed | N/A | Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia | January 2011 | April 2016 |
NCT04755517 | Enrolling by invitation | N/A | Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) | June 9, 2020 | December 31, 2025 |
NCT06273553 | Not yet recruiting | Phase 1/Phase 2 | A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 | March 2024 | December 2027 |
NCT06258564 | Not yet recruiting | The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization | May 1, 2024 | July 1, 2025 | |
NCT05405270 | Recruiting | Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment | June 1, 2022 | December 2026 | |
NCT05851079 | Recruiting | Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions | December 10, 2021 | November 30, 2024 | |
NCT03274206 | Unknown status | Phase 2 | A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) | August 30, 2017 | August 2020 |
NCT04788849 | Unknown status | Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples | March 8, 2021 | February 28, 2022 | |
NCT02149030 | Unknown status | Phase 4 | Effectiveness of Cervical Screening in HPV Vaccinated Women | March 2014 | January 2024 |
NCT03366493 | Unknown status | Phase 3 | The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection | December 7, 2017 | December 7, 2018 |